Progress in clinical neurosciences: Treatment of Alzheimer's disease and other dementias--review and comparison of the cholinesterase inhibitors. (Q35015451)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Progress in clinical neurosciences: Treatment of Alzheimer's disease and other dementias--review and comparison of the cholinesterase inhibitors.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

Europe PubMed Central

Progress in clinical neurosciences: Treatment of Alzheimer's disease and other dementias--review and comparison of the cholinesterase inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Alzheimer's disease

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Christopher Patterson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Canadian Journal of Neurological Sciences

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

306-314

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

How many patients complete an adequate trial of donepezil?

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between cholinesterase inhibitor and Pisa syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible association between donepezil and worsening Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous rupture of oesophagus (Boerhaave's syndrome) related to rivastigmine.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rivastigmine. A review of its use in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil and paroxetine: possible drug interaction

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil in the treatment of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing individual patients for cognitive benefits from acetylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinesterase inhibitors: A new class of psychotropic compounds

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of anticholinergic medications by older adults with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: epidemiology and management

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of donepezil for vascular dementia: preliminary clinical experience

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary incontinence: an unrecognised adverse effect with donepezil.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Galantamine: a review of its use in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Introduction

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinergic markers in elderly patients with early signs of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-label study of donepezil in traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil for Huntington's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

A case of Korsakoff's syndrome improved by high doses of donepezil

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

An overview of common non-Alzheimer dementias

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy for early Alzheimer's disease: what are we waiting for?

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of new black box warnings and withdrawals for prescription medications

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Extrapyramidal side effects in a patient treated with risperidone plus donepezil

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypnopompic hallucinations with donepezil

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil for Down's syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dementia and adult-onset unprovoked seizures

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Should the Mini Mental State Examination be used to monitor dementia treatments?

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Recognition, Assessment and Management of Dementing Disorders: Conclusions from the Canadian Consensus Conference on Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines on drug treatments for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Aricept-induced nightmares in Alzheimer's disease: 2 case reports.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000216X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S031716710000216X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12463485%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35015451&oldid=1628751705"